{"schema_version":"secwatch.filing_event.v1","accession":"0001193125-23-080510","form_type":"8-K","ticker":"DCTH","cik":"0000872912","company_name":"DELCATH SYSTEMS, INC.","filed_at":"2023-03-27T23:59:59+00:00","discovered_at":"2026-05-14T18:03:48.331147+00:00","generated_at":"2026-06-17T16:03:11.918895+00:00","sec_items":["2.02","9.01"],"event_type":"other_material","sentiment":"positive","materiality_score":0.75,"calibrated_materiality_score":0.75,"confidence":"high","headline":"Delcath Systems secures up to $85M financing led by Vivo Capital, $25M upfront","bullets":["Financing includes $24.9M in Series F Convertible Preferred and two warrant tranches totaling $59.8M.","Tranche A warrants ($34.9M) exercisable until 3/31/2026 or 21 days after FDA approval of HEPZATO.","Tranche B warrants ($24.9M) exercisable until 3/31/2026 or 21 days after $10M quarterly HEPZATO revenue.","Conversion and exercise require stockholder approval; funding expected to cover through PDUFA date of Aug 14, 2023 and commercialization.","Participants include Vivo Capital, Logos Capital, BVF Partners, Stonepine Capital, Serrado Capital, and existing investor Rosalind Advisors."],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-23-080510","json":"https://secwatch.observer/filing/0001193125-23-080510.json","markdown":"https://secwatch.observer/filing/0001193125-23-080510.md","text":"https://secwatch.observer/filing/0001193125-23-080510.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/872912/000119312523080510/0001193125-23-080510-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/872912/000119312523080510/d382414d8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-17T16:03:11.918895+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"864eee01d5deadb487575b69a15bf6aeeea97057","claim":"DELCATH SYSTEMS, INC. reported financial results for the fiscal quarter and year ended December 31, 2022.","evidence_excerpt":"On March 27, 2023, Delcath Systems, Inc. (the “Company”) issued a press release, furnished as Exhibit 99.1 and incorporated in this Item 2.02 by reference, announcing its financial results for the fiscal quarter and year ended December 31, 2022.","evidence_source":"SEC 8-K Item 2.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/872912/000119312523080510/0001193125-23-080510-index.htm","confidence":0.95,"family_label":"Earnings Releases","details":[{"label":"Period","value":"the fiscal quarter and year ended December 31, 2022"},{"label":"Result","value":"reported results"}],"fact_type":"earnings_release"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}